Home Business 25 shares of Lu Stock Connect Masukura over 30%, Fuxiang Pharmaceutical has the largest increase_Securities Times

25 shares of Lu Stock Connect Masukura over 30%, Fuxiang Pharmaceutical has the largest increase_Securities Times

by admin
</p> <p> 25 shares of Lu Stock Connect Masukura over 30%, Fuxiang Pharmaceutical has the largest increase_Securities Times<br /> news.google.com/__i/rss/rd/articles/images/public.css” />news.google.com/__i/rss/rd/articles/images/share_style0_16.css” />

news.google.com/__i/rss/rd/articles/images/css1.css” rel=”stylesheet” type=”text/css” />

Home> News> Finance

25 shares of Lu Stock Connect Masukura over 30%, Fuxiang Pharmaceutical has the largest increase

2021-12-02 08:48

Source: Securities Times

Author: Que Fusheng

Securities Times

Que Fusheng

2021-12-02 08:48

According to the Securities Times Internet report, Wind statistics show that as of December 1, a total of 810 stocks have been granted by Landcom Masukura. Among them, there are 25 stock holdings with a month-on-month increase of more than 30%. The largest month-on-month increase is Fuxiang Pharmaceutical. The latest holding of 6.7124 million shares by Lu Stock Connect, a month-on-month increase of 450.64%; the largest increase from the previous month. There are also stocks such as China Haiphong, Lihua Co., Ltd., Hailian Jinhui, Baiya Co., Ltd., and Orient Risen.

Statement: The Securities Times strives to be truthful and accurate. The content mentioned in the article is for reference only and does not constitute substantive investment advice. The operation is at your own risk accordingly.

  • Securities Times APP
  • WeChat public account


  • 3927181

    25 shares of Lu Stock Connect Masukura over 30%, Fuxiang Pharmaceutical has the largest increase

    6878

    Finance

    news

    1429

    Que Fusheng

    2021-12-02

    .

    0 comment
    0

    You may also like

    Leave a Comment

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

    Privacy & Cookies Policy